We are live on ! Find out more
KCM

Kynam Capital Management Portfolio holdings

AUM $1.62B
1-Year Est. Return 138.67%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+138.67%
3 Year Est. Return
+268.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
–
Cap. Flow
+$207M
Cap. Flow %
110.8%
Top 10 Hldgs %
68.58%
Holding
32
New
32
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$30.8M
2
XENE icon
Xenon Pharmaceuticals
XENE
+$20M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
+$17.7M
4
GOSS icon
Gossamer Bio
GOSS
+$12.1M
5
BIIB icon
Biogen
BIIB
+$10.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
26
DELISTED
Radius Health, Inc.
RDUS
$1.34M 0.72%
+194,082
New +$2.85M
COGT icon
27
Cogent Biosciences
COGT
$6.79B
$1.29M 0.69%
+150,000
New +$1.3M
AKUS
28
DELISTED
Akouos Inc
AKUS
$842K 0.45%
+99,008
New +$888K
NGNE icon
29
Neurogene
NGNE
$696M
$709K 0.38%
+7,350
New +$895K
GYRE icon
30
Gyre Therapeutics
GYRE
$662M
$101K 0.05%
+14,799
New +$253K
GBT
31
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$15K 0.01%
+100,000
New +$3.1M
ALLK
32
CALL
DELISTED
Allakos
ALLK
$2K ﹤0.01%
+74,500
New +$6.1M
1
2

Similar funds

IPW
Invictus Private Wealth Denver, Colorado $1.62B AUM 22.63% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.62B AUM 17.7% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

Kynam Capital Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Kynam Capital Management, which disclosed 32 positions worth $187M. Its ten largest holdings account for 69% of the portfolio.

Its largest position is Global Blood Therapeutics, Inc.: 992,949 shares worth $29.1M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets.

  • Kynam Capital Management's largest Q4 2021 buy was Global Blood Therapeutics, Inc.: 992,949 shares worth $29.1M.
  • Kynam Capital Management's ten largest holdings make up 69% of its $187M portfolio in Q4 2021.
  • Kynam Capital Management disclosed 32 positions in Q4 2021, its first 13F filing on record.

Based on Kynam Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.